\'TAK-003\', a live attenuated dengue vaccine, is developed by which country?

Question

TAK-003, developed by Japan\'s Takeda, is a live-attenuated dengue vaccine containing weakened strains of all four virus serotypes. It\'s WHO prequalified, the second dengue vaccine after CYD-TDV. Recommended for children aged 6-16 in high-burden, high-transmission areas, it aims to combat dengue.

GKToday Admin · Accepted Answer

Japan TAK-003, developed by Japan\'s Takeda, is a live-attenuated dengue vaccine containing weakened strains of all four virus serotypes. It\'s WHO prequalified, the second dengue vaccine after CYD-TDV. Recommended for children aged 6-16 in high-burden, high-transmission areas, it aims to combat dengue.

Current Affairs

Daily MCQs

Monthly MCQs

Topic Wise CA MCQs

Current Affairs Articles

CA MCQs in Other Languages

GK MCQs Section

SSC/RRB/States Level MCQs